Skip to main content
. 2015 Jul 5;232(18):3431–3441. doi: 10.1007/s00213-015-3995-x

Fig. 5.

Fig. 5

Sucrose consumption following administration of GSK1521498 or naltrexone: there was a significant dose-dependent decrease in sucrose consumption with both GSK1521498 and naltrexone, which became significant at a dose of 1 mg/kg. *p < 0.05